Abstract
Abstract
This disclosure outlines a protocol to enhance the clinical efficacy of mRNA-based cancer therapeutics by integrating targeted acoustic-vortex delivery systems with systemic physiological stabilization. Traditional mRNA therapeutics face barriers in tumor microenvironment (TME) penetration and immune-cell recruitment. By utilizing GCI-developed acoustic-vortex resonance to modify tissue permeability and local interstitial pressure, this protocol provides a non-invasive, hardware-based method to concentrate therapeutic payloads at tumor sites. This is a purely conceptual, builder-ready framework intended to be integrated into existing clinical research pipelines.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Caldwell, Michael Victor Mr., "Technical Disclosure: GCI Oncology mRNA-Acoustic Vortex-Synergy Protocol (GCI-OAS v1.0)", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/10892